Preterm Labor Treatment Market by Drugs (Tocolytic Drugs (Beta – Mimetic, Calcium Channel Blockers, NSAIDS), Corticosteroids, Magnesium Sulphate, Antibiotics, Others)), By Dosage Form (Tablets, Capsules, Injections), By End User (Hospitals, Pediatric and Neonatal Clinics, Nursing Homes, Pharmacy) and Geography



Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Preterm Labor Treatment Market report gives a comprehensive outlook across the globe with special emphasis on key regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa (MEA). This report on global market gives historical, current, and future market sizes (US$ Mn) of drugs (tocolytic drugs (beta – mimetic, calcium channel blockers, nsaids), corticosteroids, magnesium sulphate, antibiotics, others)), dosage form (tablets, capsules, injections), end user (hospitals, pediatric and neonatal clinics, nursing homes, pharmacy) and geographic regions. This report studies global market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the market report includes regulatory scenario and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the report include suppliers, manufacturers, marketers, policymakers engaged in manufacturing and supply of preterm labor treatment market In April 2016, AMAG Pharmaceuticals introduced FDA approved single dose, preservative free Makena to reduce risk of preterm birth. The flare-up of the Covid-19 pandemic and high danger of preterm birth related with Covid-19 disease has upsurged the interest for its testing arrangements. As indicated by the information distributed by CDC, pregnant women with Covid-19 are at increased danger for basic entanglements and may be at high danger for preterm birth.

Preterm Labor Treatment Market Summary

Study Period


Base Year




Largest Market

North America

Fastest Growing Market

Asia Pacific
Preterm Labor Treatment Market Dynamics Dynamics

Increase in premature birth cases and rapid increase birthrate are major driving factors of preterm labor treatment market. As per WHO statistics, every year 15Mn babies are born. Increase in technological advancements, increasing demand for preterm therapeutics and diagnostics, increase in support of government, increase in R&D investments by market players are expected to propel the growth of preterm labor treatment market. However, lack of awareness, stringent regulatory framework, high costs associated with the treatment will hamper the growth of preterm labor treatment market.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Preterm Labor Treatment Market Segmentation

By Drug
  • Tocolytic Drugs
  • Beta – Mimetic
  • Calcium Channel Blockers
  • Corticosteroids
  • Magnesium Sulphate
  • Antibiotics
  • Others
By Dosage Form
  • Tablets
  • Capsules
  • Injection
By End User
  • Hospitals
  • Pediatric and Neonatal Clinics
  • Nursing Homes
  • Pharmacy
By Geography
  • Latin America
  • North America
  • Asia Pacific
  • Middle East and Africa
  • Europe


Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

  • Pfizer (U.S.)
  • Novartis (Switzerland)
  • Merck & Co (U.S.)
  • Sanofi (France)
  • Johnson & Johnson (U.S.)
  • GlaxoSmithKline (UK)
  • AstraZeneca (UK)
  • Cipla (India)